ABT - Abbott Laboratories
Close
113.27
0.510 0.450%
Share volume: 4,320,043
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$112.76
0.51
0.45%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-17 | 2023-05-04 | 2023-08-03 | 2023-11-01 | 2024-02-16 | 2024-05-02 | 2024-07-31 | |
| Total revenue | 10.410 B | 10.091 B | 9.747 B | 9.978 B | 10.143 B | 10.241 B | 9.964 B | 10.377 B | |
| Cost of revenue | 4.629 B | 4.593 B | 4.331 B | 4.483 B | 4.605 B | 4.556 B | 4.463 B | 4.603 B | |
| Gross profit | 5.781 B | 5.498 B | 5.416 B | 5.495 B | 5.538 B | 5.685 B | 5.501 B | 5.774 B | |
| -4.90% | -1.49% | 1.46% | 0.78% | 2.65% | -3.24% | 4.96% | |||
| Operating expenses | 3.513 B | 3.698 B | 3.416 B | 3.455 B | 3.395 B | 3.424 B | 3.643 B | 3.634 B | |
| Selling general and admin | 2.731 B | 2.973 B | 2.762 B | 2.740 B | 2.723 B | 2.724 B | 2.959 B | 2.936 B | |
| Research and development | 782.000 M | 725.000 M | 654.000 M | 715.000 M | 672.000 M | 700.000 M | 684.000 M | 698.000 M | |
| Total expenses | 8.640 B | 8.787 B | 8.238 B | 8.436 B | 8.496 B | 8.461 B | 8.578 B | 8.708 B | |
| 1.70% | -6.25% | 2.40% | 0.71% | -0.41% | 1.38% | 1.52% | |||
| Operating income | 1.770 B | 1.304 B | 1.509 B | 1.542 B | 1.647 B | 1.780 B | 1.386 B | 1.669 B | |
| Ebit | 1.770 B | 1.304 B | 1.509 B | 1.542 B | 1.647 B | 1.780 B | 1.386 B | 1.669 B | |
| Pretax income | 1.758 B | 1.320 B | 1.562 B | 1.636 B | 1.671 B | 1.795 B | 1.436 B | 1.607 B | |
| -24.91% | 18.33% | 4.74% | 2.14% | 7.42% | -20.00% | 11.91% | |||
| Income tax | 323.000 M | 287.000 M | 244.000 M | 261.000 M | 235.000 M | 201.000 M | 211.000 M | 305.000 M | |
| Net income basic | 1.435 B | 1.033 B | 1.318 B | 1.375 B | 1.436 B | 1.594 B | 1.225 B | 1.302 B | |
| -28.01% | 27.59% | 4.32% | 4.44% | 11.00% | -23.15% | 6.29% | |||
| Net income | 1.435 B | 1.033 B | 1.318 B | 1.375 B | 1.436 B | 1.594 B | 1.225 B | 1.302 B | |
| -28.01% | 27.59% | 4.32% | 4.44% | 11.00% | -23.15% | 6.29% |